You are here

  • Home
  • Archive
  • Volume 76, Issue Suppl 2
  • FRI0225 Anemia is a better predictor for radiographic damage in rheumatoid arthritis than das28 when determined before start of tocilizumab-treatment – a secondary analysis from the act-ray trial

Citation Tools

Article menu

Download PDFPDF

Poster Presentations
Rheumatoid arthritis - other biologic treatment
FRI0225 Anemia is a better predictor for radiographic damage in rheumatoid arthritis than das28 when determined before start of tocilizumab-treatment – a secondary analysis from the act-ray trial
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Möller B, Scholz G, Dougados M, et al
FRI0225 Anemia is a better predictor for radiographic damage in rheumatoid arthritis than das28 when determined before start of tocilizumab-treatment – a secondary analysis from the act-ray trial
Annals of the Rheumatic Diseases 2017;76:569.